In this article
NAD+, NMN and NR are related molecules, but they are not three names for the same ingredient. NAD+ is a coenzyme; NMN and NR are precursors involved in NAD metabolism. For buyers in Bali, this distinction matters because a study of an oral precursor cannot establish the outcome of a NAD+ pen or an intravenous service.
NAD+, NMN and NR: a clear comparison
| Name | What it refers to | What to check in a study |
|---|---|---|
| NAD+ | Nicotinamide adenine dinucleotide in its oxidized form | Was NAD+ itself administered, and by which route? |
| NMN | Nicotinamide mononucleotide, a precursor | Which population and which outcomes were studied? |
| NR | Nicotinamide riboside, another precursor | Was the outcome a NAD-related marker or a clinical benefit? |
The common NAD connection explains why these products appear together in searches. It does not create a single interchangeable category. “NAD booster” is a broad description; the ingredient, route and actual finding still need to be named.
What the oral NR trial contributes
A randomized NR supplementation study in middle-aged and older adults examined NAD-related metabolism. Its oral formulation and measured outcomes are central to what can be concluded. It does not establish that injecting NAD+ produces the same result, nor that a changed blood marker necessarily means someone will feel more energetic.
When reading a product claim, look for the step between “the marker changed” and “people benefited”. If the study did not measure the promised outcome, that step is an inference. It should remain visible instead of disappearing into a broad anti-aging headline.
Why the NMN population matters
The Science study of NMN examined a selected group of women with prediabetes and overweight or obesity. Its findings concern that intervention and population. They cannot simply be extended to every healthy tourist, every age group or a different administered molecule.
This is also why a study can be encouraging without resolving a buying decision. Mechanistic interest, a result in a selected group and evidence for the exact product are different levels of the question. Keeping them separate is more useful than declaring a universal winner among NAD+, NMN and NR.
A NAD+ pen is not an infusion or a capsule
A small NAD+ infusion study followed metabolites during intravenous administration. That design does not establish a conversion between an infusion, oral precursor supplementation and a pen. Equal milligram amounts across those products are not equal proven exposure or effect.
Our NAD+ listing describes a 1000 mg pen. The number is total labelled content. The page does not make NMN or NR an ingredient of that pen. Those substances are discussed here for comparison, not presented as additional catalogue items.
If your question concerns the difference between a product and a clinic service, the NAD+ pen-versus-IV guide addresses that separate decision.
Compare the promise before comparing the format
In Bali, an enquiry may begin with a longevity programme, an infusion advertisement or an oral supplement someone already takes. Write down the exact promise you want to evaluate: a measured biochemical change, a symptom or a clinical outcome. Then attach the actual ingredient and route to that promise.
A useful comparison note has four lines: ingredient; form; studied population; measured outcome. If a product explanation cannot fill those lines without switching to another molecule's research, it has not answered the question. Ask for the relevant paper rather than another broad statement about cellular energy.
For a catalogue enquiry, use the product link and ask about its own documentation. For decisions involving persistent symptoms, existing treatment or adding an injectable product, seek a clinical review. A biochemical pathway diagram does not resolve personal suitability.
Questions readers ask
Is NMN already NAD+ in a different package?
No. It is a different molecule involved in the pathway. A related role does not make ingredients or formulations identical.
Can I convert a capsule amount into a pen amount?
No valid conversion follows from the labels or the studies discussed here. Route, molecule and formulation differ.
Which one has been proven to make everyone feel younger?
The cited trials do not establish that claim. Their specific outcomes are more informative than an undefined promise of feeling younger.
Sources
- Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults
- Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women
- A Pilot Study Investigating Changes in the Human Plasma and Urine NAD+ Metabolome During a 6 Hour Intravenous Infusion of NAD+
Source and editorial checks completed. How these articles are prepared.
